A narrative review of using prescription drug databases for comorbidity adjustment: A less effective remedy or a prescription for improved model fit?

Abstract

BACKGROUND\nThe use of claims data for identifying comorbid conditions in patients for research purposes has been widely explored. Traditional measures of comorbid adjustment included diagnostic data (e.g., ICD-9-CM or ICD-10-CM codes), with the Charlson and Elixhauser methodology being the two most common approaches. Prescription data has also been explored for use in comorbidity adjustment, however early methodologies were disappointing when compared to diagnostic measures.\n\n\nOBJECTIVE\nThe objective of this methodological review is to compare results from newer studies using prescription-based data with more traditional diagnostic measures.\n\n\nMETHODS\nA review of studies found on PubMed, Medline, Embase or CINAHL published between January 1990 and December 2020 using prescription data for comorbidity adjustment. A total of 50 studies using prescription drug measures for comorbidity adjustment were found.\n\n\nCONCLUSIONS\nNewer prescription-based measures show promise fitting models, as measured by predictive ability, for research, especially when the primary outcomes are utilization or drug expenditure rather than diagnostic measures. More traditional diagnostic-based measures still appear most appropriate if the primary outcome is mortality or inpatient readmissions.